PepperLime Health Acquisition in an 8-K said its shareholders unanimously approved extending the SPAC’s merger deadline from Oct. 19, which is two years after the SPAC’s IPO, until April 19, 2024. PepperLime Health said 4,596,816 shares were voted in favor of pushing the termination date back to April, with no opposition.
The SPAC’s sponsor has agreed to deposit 6 cents a share per month into trust for the first three months of the extension, then 2 cents a share for each month thereafter until the new deadline.
PepperLime Health said 433,061 shares were redeemed.
The SPAC raised $150 million in an October 2021 IPO with plans to target companies at the intersection of technology and consumer health and wellness. Read more.
